However, SMAD4 re-expression in BxPC3 PCCs fails to suppress angiogenesis in vivo [63], and blocking TGF-β signaling suppresses tumor growth, metastasis, and angiogenesis in orthotopic mouse models [13, 64, 65]. The gene discussed is TGFB1; the disease is neoplasm.